RNA synthesis platform to target synthesis lengths greater than 100-nt, large-scale GMP manufacturing, and novel therapeutic modifications in collaboration with industry partners Advanced-stage technology with over six years of development at the Wyss Institute at Harvard University, co-founded by Dr. George Church of Harvard Medical School, and the first spin-out from the Northpond Labs Alliance […]

This week, KeyGene installed an MGI DNA-sequencing machine: a DNBSEQ – G400RS. KeyGene is the first to acquire and install this new sequencer in the Netherlands, a leading country in plant breeding and plant research. “The new MGI sequencing technology offers a range of new possibilities for technology innovation for crop improvement’ said Dick Roelofs, […]

New sequencing technologies and capabilities will accelerate the genomic discoveries and clinical insights needed to transform human health Revolutionary NovaSeq X Series sets new benchmark for speed, scale, accuracy, and sustainability SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced multiple breakthrough sequencing innovations at its inaugural […]

Funding will support expanded offerings for drug development, regenerative medicine as fiber-optic instrument-maker broadens presence in life science market New investment will also bolster leadership team and support U.S. expansion AMSTERDAM – Optics11 Life, the fiber optics life science instrumentation company, announced today €5 million in new venture capital from FORWARD.one and returning investor Value […]

New technology enables highest levels of accuracy at immense scale, with the power to sequence more than 20,000 genomes per year Our most sustainable high-throughput sequencer delivers 90% reduction in packaging and 50% reduction in plastic waste, and eliminates dry ice shipments, expanding global access to genomic medicine SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a […]

Monoclonal antibodies specific and potent against a variety of SARS-CoV-2 protein domains Wide selection of high purity SARS-CoV-2 recombinant proteins Robust and optimized ELISA kits to quantify SARS-CoV-2 virus-triggered human IgM/IgG IRVINE, Calif. — MP Biomedicals, LLC has recently expanded its portfolio of COVID-19 related research products to include a wide selection of highly pure SARS-CoV-2 […]

bit.bio adds two new human cell products to address the translation gap and accelerate research and drug discovery for neurodegenerative disease bit.bio announces an expansion to its product portfolio to accelerate research into neurodegenerative diseases Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) disease model offer a scalable and reproducible in vitro system to model […]

CAMBRIDGE, Mass. & BERN, Switzerland — Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies and, the Translational Research Unit (TRU) platform of University of Bern, that develops novel workflows for tissue microarray (ngTMA ® ) construction, announce a collaborative agreement to promote multiplexed immunofluorescence (mIF) assays […]

SAN DIEGO — iXCells Biotechnologies (“iXCells” or the “Company”), a high growth provider of cell-based products and discovery services to the academic, biotech and pharmaceutical communities worldwide, with special focus on primary and induced pluripotent stem cell (“iPSC”) derived cellular models, today announced receiving a growth investment from Connecticut-based Great Point Partners (“GPP”), a private […]

The expansion is part of the company’s growth strategy for North America and will foster collaboration with life science companies and academia An inauguration event will take place on October 12, featuring presentations from collaborators at NeoGenomics, Takeda and Kymera ZURICH and CAMBRIDGE, Mass. Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, […]